These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7639084)

  • 21. Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics.
    Beckmann H; Saavedra JM; Gattaz WF
    Biol Psychiatry; 1984 May; 19(5):679-84. PubMed ID: 6145452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
    Leckman JF; Cohen DJ; Shaywitz BA; Caparulo BK; Heninger GR; Bowers MB
    Arch Gen Psychiatry; 1980 Jun; 37(6):677-81. PubMed ID: 6155891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raised cerebrospinal fluid phenylacetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia?
    Sandler M; Ruthven CR; Goodwin BL; King GS; Pettit BR; Reynolds GP; Tyrer SP; Weller MP; Hirsch SR
    Commun Psychopharmacol; 1978; 2(3):199-202. PubMed ID: 699534
    [No Abstract]   [Full Text] [Related]  

  • 24. A longitudinal study of the relationships between psychometric test scores, offence history and the plasma concentrations of phenylacetic and 5-hydroxyindoleacetic acids in seven inmates of a prison for the psychiatrically disturbed.
    Davis BA; Durden DA; Pease K; Yu PH; Green C; Gordon A; Menzies R; Templeman R; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jul; 17(4):619-35. PubMed ID: 7689735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment.
    Sharma RP; Javaid JI; Janicak PG; Davis JM; Faull K
    Biol Psychiatry; 1993 Aug; 34(3):128-34. PubMed ID: 8104508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjective wellbeing under quetiapine treatment: effect of diagnosis, mood state, and anxiety.
    Lambert M; Naber D; Karow A; Huber CG; Köhler J; Heymann J; Schimmelmann BG
    Schizophr Res; 2009 May; 110(1-3):72-9. PubMed ID: 19321310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of phenylacetic acid across the blood-cerebrospinal fluid barrier.
    Pedemonte WA; Mosnaim AD; Bulat M
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):111-6. PubMed ID: 935645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are psychoactive-drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiatric disorders?
    Diebold K; Michel G; Schweizer J; Diebold-Dörsam M; Fiehn W; Kohl B
    Pharmacopsychiatry; 1998 Mar; 31(2):60-7. PubMed ID: 9562210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements.
    Sabelli HC; Fawcett J; Gusovsky F; Javaid JI; Wynn P; Edwards J; Jeffriess H; Kravitz H
    J Clin Psychiatry; 1986 Feb; 47(2):66-70. PubMed ID: 3944066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia.
    Sasayama D; Hattori K; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
    Schizophr Res; 2012 Aug; 139(1-3):201-6. PubMed ID: 22742979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher cerebrospinal fluid angiotensin-converting enzyme levels in neuroleptic-treated than in drug-free patients with schizophrenia.
    Wahlbeck K; Ahokas A; Miettinen K; Nikkilä H; Rimón R
    Schizophr Bull; 1998; 24(3):391-7. PubMed ID: 9718631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A versatile new sustained-action neuroleptic: pipotiazine palmitate in psychiatric practice.
    Johnston RE; Niesink F
    J Int Med Res; 1979; 7(3):187-93. PubMed ID: 37133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenylacetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentration values.
    Sandler M; Ruthven CR; Goodwin BL; Lees A; Stern GM
    J Neurol Neurosurg Psychiatry; 1982 Apr; 45(4):366-8. PubMed ID: 7077347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial differences between rapid neuroleptic response psychosis and delayed neuroleptic response psychosis.
    Sautter F; McDermott B; Garver D
    Biol Psychiatry; 1993 Jan; 33(1):15-21. PubMed ID: 8093593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary phenylacetic acid excretion in depressive patients.
    González-Sastre F; Mora J; Guillamat R; Queraltó JM; Alvarez E; Udina C; Massana J
    Acta Psychiatr Scand; 1988 Aug; 78(2):208-10. PubMed ID: 3223321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin and glucagon in plasma and cerebrospinal fluid in suicide attempters and healthy controls.
    Bendix M; Uvnäs-Moberg K; Petersson M; Kaldo V; Åsberg M; Jokinen J
    Psychoneuroendocrinology; 2017 Jul; 81():1-7. PubMed ID: 28391069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment.
    Widerlöv E; Lindström LH; Besev G; Manberg PJ; Nemeroff CB; Breese GR; Kizer JS; Prange AJ
    Am J Psychiatry; 1982 Sep; 139(9):1122-6. PubMed ID: 6126127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.